AI gen brain scan concept

Telix wins fast track status from US FDA for new brain cancer PET scan imaging agent

Telix Pharmaceuticals (ASX:TLX) has announced its receipt of fast track status from the US FDA within…

Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run

International plans for Telix – proudly boasting its intentions to list on the NASDAQ for a…